Next |
home / stock / iova / iova message board
Subject | By | Source | When |
---|---|---|---|
Citing feedback, the company announced that the design | jondoeuk | investorshub | 07/10/2023 5:02:29 PM |
$IOVA Price gaining | Watts Watt | investorshub | 07/10/2023 5:37:07 AM |
Do we have a winner?Turn around time? | jondoeuk | investorshub | 07/08/2023 7:59:28 AM |
$IOVA Lets go go go go... Up up and away we go. | Watts Watt | investorshub | 07/05/2023 10:58:06 PM |
$IOVA bulls and bears | jondoeuk | investorshub | 07/05/2023 5:31:05 PM |
(OT): The importance of CD4+ T-cells https://aacrjournals.org/clincancerres/arti | jondoeuk | investorshub | 07/05/2023 12:26:26 AM |
$IOVA The now | Watts Watt | investorshub | 06/30/2023 9:57:52 PM |
where is the squeeze? | ClayTrader | investorshub | 06/30/2023 7:49:12 PM |
Price now | jondoeuk | investorshub | 06/25/2023 12:55:42 PM |
In addition, use a manufacturing process that promises | jondoeuk | investorshub | 06/25/2023 12:09:45 AM |
They combined the CRISPRomics platform with CRISPR2 tech, | jondoeuk | investorshub | 06/25/2023 12:08:01 AM |
(OT): KSQ Therapeutics is working on gene-edited TIL | jondoeuk | investorshub | 06/25/2023 12:04:59 AM |
MomentumIts now | ClayTrader | investorshub | 06/24/2023 11:22:11 PM |
ImmuT Finder is a novel T-cell immunoregulatory target | jondoeuk | investorshub | 06/23/2023 11:30:19 PM |
Preclinical data https://ascopubs.org/doi/10.1200/JCO.2021.39.15 suppl.e14506 https://aacrjournals.o | jondoeuk | investorshub | 06/23/2023 11:23:58 PM |
(OT): GRIT Bio was founded in 2019 and | jondoeuk | investorshub | 06/23/2023 11:19:55 PM |
$IOVA we got news | Porterhouse10 | investorshub | 06/17/2023 1:49:41 AM |
$IOVA Price gaining | jondoeuk | investorshub | 06/15/2023 11:37:04 PM |
$IOVA The now | dinogreeves | investorshub | 06/15/2023 1:54:42 AM |
what do you make of this data? | jondoeuk | investorshub | 06/14/2023 11:00:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Iovance Biotherapeutics Inc. Company Name:
IOVA Stock Symbol:
NASDAQ Market:
Iovance Biotherapeutics Inc. Website:
2024-04-16 18:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-05 05:03:00 ET If you're looking to add some growth to your portfolio, a great way to do it is by picking up shares of a biotech company with a recently approved product. Such a treatment will represent a brand new revenue driver for the company -- and sometimes, even its first one ...
SAN CARLOS, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) ("Iovance" or the "Company"), a biote...